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Crude extract of Buddleja asiatica Lour and its fractions, chloroform (F1), ethyl acetate (F2) and n-
butanol (F3) were evaluated for antibacterial, antifungal, antispasmodic and Ca++ antagonist activities. 
The antibacterial activity was performed against 11 types of bacteria. The crude extract and fractions F2 
and F3 exhibited significant activity, while F1 showed low activity in killing the Shigella flexenari, 
Sternostoma boydi and Escherichia coli. In the rest bacteria, the crude extract and all the fractions (F1 
to F3) revealed minimum to nil inhibitory effect. The fungicidal activity of the crude extract and all the 
fractions (F1 to F3) was also performed against six different fungi. The crude extract and fractions F1 
and F3 displayed significant activity, while fraction F2 showed moderate activity against Fusarium 
solani. In the case of Microsporum canis, the crude extract and fraction F3 showed high activity but in 
the other four fungi, the inhibition area exhibited optimum to nil activity in crude extract and all the 
fractions (F1 to F3). In isolated rabbit jejunum preparations, B. asiatica crude extract caused 
concentration-dependent (0.03 to 1.0 mg/ml) relaxation of spontaneous and high K+ (80 mM)-induced 
contractions. The results indicate the antibacterial, antifungal, antispasmodic and Ca++ antagonist 
potential of B. asiatica Lour. 
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INTRODUCTION 
 
The genus Buddleja belonging to the family Scrophu-
lariaceae, comprises approximately 100 species. In 
Pakistan, it is represented by four species (Abdullah, 
1974). This plant has been used medicinally in different 
regions in the past and present. It has been used for skin 
complaints (Pande et al., 2007) and as an abortifacient 
(Nepal, 1970). A paste of its roots is used as a tonic 
when mixed with rice water (Gage, 1904). This plant is 
also used as a medicine for skin disease, abortion and as 
a cure for loss of weight (Guerrero, 1921). Roots and lea-
ves of this plant are employed to treat head tumor 
(Hartwell, 1970). A fusion of roots is used in the treatment 
of malaria (Reis and Von, 1973). The leaves of Buddleja 
asiatica have a hypotensive effect on cats and dogs, 
probably due to α-adrenoceptor blocking activity (Singh et 
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al., 1980). It is also reported that essential oil of the 
leaves has in-vitro antifungal activities (Garg and Dengre, 
1992). The flowers are used in the treatment of cystitis 
and cold (Lee et al., 2008) and to treat edema (Zheng 
and Xing, 2009). The extracts of B. asiatica also showed 
strong cyclo-oxygenase inhibitory activities in elicited rat 
peritoneal leukocytes (Liao et al., 1999). The ethno-
pharmacological and chemo-taxonomic importance of the 
genus Buddleja prompted us to carry out investigation on 
B. asiatica since no work has been carried out on the 
antimicrobial activities of the plants and different 
extracts/fractions. Also, in this investigation, the evidence 
that B. asiatica exhibited spasmolytic effect, which is 
mediated through Ca++ antagonist mechanism was shown.  
 
 
MATERIALS AND METHODS 
 
The whole plant of B. asiatica was collected from Banda Piran, 
Siran valley, 2900 meters above the sea level, in the of District 
Mansehra in   October,   2007.  It  was  identified  by  Professor  Dr.  
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Manzoor Ahmad, Plant Taxonomist, Department of Botany, 
Government Degree College, Abbotabad, Pakistan. A voucher 
specimen (Accession no. B-0015) has been deposited in the 
herbarium. 
 
 
Preparation of crude extract and fractions  
 
The whole plant of Buddleja asiatica was shade-dried, ground to 
powder (21 kg) and extracted with methanol (65 L) at room 
temperature for seven days. The extraction was repeated thrice. 
The combined methanolic extract was evaporated to obtain a 
greenish gummy residue (522 g) which was divided into n-hexane 
(63 g), chloroform (101 g), ethyl acetate (59 g), n-butanol (48 g) and 
water (70 g) soluble fractions.  
Fungal and bacterial strains were collected from the Institute of 
Pharmaceutical Sciences, Faculty of Pharmacy, University of 
Karachi, Karachi, Pakistan. Acetylcholine (ACh), dimethyl sulfoxide 
(DMSO), sabouraud, glucose agar and imipenem were purchased 
from Sigma Chemicals Co., St. Lous, USA. The solvents: n-butanol, 
ethyl acetate, n-hexane, chloroform and methanol were from Merck, 
Germany. Chemicals used for making physiological salt solutions: 
potassium chloride, calcium chloride, glucose, magnesium chloride, 
sodium bicarbonate, sodium dihydorgen phosphate and sodium 
chloride were obtained from BDH Laboratories, England. All 
chemicals were of analytical grade A. 
Rabbits (1.5 to 2 kg) of either sex or local breed were used in this 
study. They were housed at the Animal House of the Aga Khan 
University, maintained at 23 to 25°C and given a standard diet and 
tap water. Rabbits had free access to water, but food was 
withdrawn 24 h prior to the experiment and killed by a blow on the 
back of the head. Experiments performed complied with the rulings 
of the Institute of Laboratory Animal Resources, Commission on 
Life Sciences, National Research Council (1996) and were 
approved by the Ethical Committee of the Aga Khan University. 
 
 
Antibacterial assay 
 
The antibacterial activity was checked by the agar–well diffusion 
method (Kavanagh, 1963). In this method, one loop full of 24 h old 
culture containing approximately 104 to 106 CFU was spread on the 
surface of Mueller-Hinton agar plates. Wells were dug in the 
medium with the help of sterile metallic cork borer. Stock solutions 
of the test samples (crude extract and fractions F1 to F3) with the 
concentration of 1 mg/ml were prepared in DMSO and 100 µl 
dilutions were added in their respective wells. The antibacterial 
activity of crude extract and fractions (F1 to F3) were compared 
with the standard drug imipenem which served as the positive 
control. 
 
 
Antifungal activity 
 
The antifungal activity was determined by the agar well diffusion 
method (Kavanagh, 1963). In this method, amphotericin and 
miconazole were used as the standard drugs. The crude extract 
and fractions (F1 to F3) were dissolved in DMSO (50 mg/ 5ml). 
Sterile sabouraud’s dextrose agar medium (5 ml) was placed in a 
test tube and inoculated with the sample solutions (400 µg/ml) and 
kept in slanting position at room temperature overnight. The fungal 
culture was then inoculated on the slant. The samples were 
incubated for 7 days at 29°C and growth inhibition was observed. 
 
 
Antispasmodic effect 
 
The spasmolytic activity of the plant material was  studied  by  using  
 
 
 
 
isolated rabbit jejunum as described previously (Gilani et al., 1999). 
Respective segments of 2 cm length were suspended in 10 ml of 
Tyrode’s solution and bubbled with carbogen at 37°C. The 
composition of Tyrode’s solution in mM was: KCl, 2.68, NaCl, 
136.9, MgCl2, 1.05, NaHCO3, 11.90, NaH2PO4, 0.42, CaCl2, 1.8 and 
glucose, 5.55. A resting tension of 1 g was applied to each tissue 
and kept constant throughout the experiment. Intestinal responses 
were recorded isotonically using a Bioscience transducer and 
Harvard oscillograph. Each tissue was allowed to equilibrate for at 
least 30 min before addition of any drug, then stabilized with sub-
maximal concentration of ACh (0.3 µM) and bath fluid was 
subsequently replaced with normal Tyrode’s solution before starting 
the experiment. Under these experimental conditions, jejunum 
exhibited spontaneous rhythmic contractions, which allowed the 
testing of the relaxant (spasmolytic) effect directly, without the use 
of any agonist. 
 
 
Determination of Ca++ antagonist action 
 
To assess whether the antispasmodic effect of the plant materials is 
mediated through calcium channel blockade, high K+ (80 mM) was 
used to depolarize the preparations as described by Farre et al. 
(1991). Addition of high K+ to the tissue bath produced a sustained 
contraction. Relaxation of intestinal preparations by the plant 
material, precontracted with K+, was expressed as percent of the 
control response mediated by K+.  
 
 
Statistical analysis 
 
Data expressed were mean ± standard error of mean (SEM, n = 
number of experiments).  
 
 
RESULTS AND DISCUSSION 
 
Antibacterial activity of crude extract and various fractions 
(F1 to F3) of B. asiatica L. was performed against 11 
human pathogens including Escerichia coli, Bacillus 
subtilis, Staphylococcus aureus, Shigella flexneri, 
Sternostoma boydi, Pseudomonas aeruginosa, 
Salmonella typhi, Vibrio cholerae, Klebsiella pneumoniae, 
Pseudomonas maltophilia and Mycobacterium  leprae. 
The results are shown in Table 1. The crude extract 
displayed high to low activity in killing the S. boydi (56%), 
E. coli (44%), S. flexneri (36%), S. aureus (25%), V. 
cholera, (25%), B. subtilis (17%), M. leprae (13%) and P. 
aeruginosa (10%) but no activity was seen against S. 
typhi, K. pneumoniae and P. maltophilia. F1 was most 
effective against S. flexenari (23 %) and S. boydi (16 %), 
while less activity was seen in the case of inhibiting the 
growth of P. aerigenosa (12 %) and E. coli. F1 was totally 
ineffective against the rest of the bacteria. F2 exhibited 
significant activity against S. boydi (67%) and E. coli 
(44%), while low activity was seen in the killing of S. 
flexneri (29%), P. aeruginosa (21%), S. aureus (18%), B. 
subtilis (10%) and V. cholera (7%), but no activity was 
observed in the rest of the bacteria. The fraction F3 
revealed moderate to low activity in killing the S. 
flexneri(58%), S. boydi (32%), V. cholera (29%), E. coli 
(27%), P. aeruginosa  (17%)  and  S. aureus  (11%),  and  
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Table 1. Antibacterial activity of crude extracts and various fractions of Buddleja asiatica.  
 
Bacteria Z.I of standard drug (imipenem) Crude extract F1 F2 F3 
Z.I Inh Z.I Inh Z.I Inh Z.I Z.I 
E. coli 34 15 44 5 9 15 44 9 27 
B. subitiltis 30 5 17 ----- ----- 3 10 ----- ----- 
S. aurous 28 7 25 2 7 5 18 3 11 
S. boydi 25 14 56 4 16 16 67 8 32 
S. flexenari 31 11 36 7 23 9 29 18 58 
P. aerigenosa 30 3 10 4 12 2 21 5 17 
S. typhi 29 ----- ----- ----- ----- ----- ----- ----- ----- 
V. cholera 24 6 25 ----- ----- 3 7 7 29 
K. pneumoniae 25 ----- ----- ----- ----- ----- ----- ----- ----- 
P. maltophilia 28 ----- ----- ----- ----- ----- ----- ----- ----- 
M. leprae 31 4 13 3 10 ----- ----- 2 7 
 
Z.I = Zone of Inhibition in mm; Inh = Inhibition in %. The plates were inculcated at a concentration (mg/ml) of DMSO. 
 
 
 
Table 2. Antifungal activity of the crude extracts and various fractions of B. asiatica.  
 
Fungi Control L.G 
Crude extract F1 F2 F3 Standard drug 
L.G Inh L.G Inh L.G Inh L.G Inh Name MIC (µg/ml) 
A. flavus 100 25 71 60 40 80 20 65 35 Amphotericin-B 30 
 F. solani 100 70 66 35 65 54 46 41 59 Miconazole 105 
C. albicans 100 100 ----- 100 ----- 100 ----- 100 ----- Miconazole 20 
T. longifusus 100 50 59 44 46 65 35 55 4 Miconazole 88 
M .canis 100 40 60 80 20 75 25 35 65 Miconazole 94 
C. glaberata 100 100 ----- 100 ----- 100 ----- 100 ----- Miconazole 103 
 
L.G= Linear growth in mm; Inh = Inhibition in %. The plates were inculcated at a concentration (mg/ml) of DMSO. 
 
 
 
Table 3. Concentration-dependent inhibitory effect 
of the crude extract of B. asiatica on spontaneous 
contractions of isolated rabbit jejunum 
preparations.  
 
Concentration (mg/ml) Inhibition (%) 
0.03 5.7 ± 4.8 
0.1 11.7 ± 9.3 
0.3 38 ± 8.5 
1.0 100 
 
Values shown are mean ± SEM (n = 3). 
 
 
 
did not show any activity against the others. These 
results were compared with standard drug (imipenem) 
which was more effective by showing maximum inhibition 
zones (Table 1). 
The fungicidal activity of the crude extract and various 
fractions (F1 to F3) of B. asiatica was evaluated against 
six fungi including Aspergillus flavus, Fusarium solani, 
Candida lbicans, Trichophyton longifusus, Microsporum 
canis and Candida glaberata. The results (Table 2) 
indicated that the crude extract and fractions F1 and F3 
displayed significant activity, while fraction F2 showed 
moderate activity in killing F. solani. In the case of A. 
flavus, and T. longifusus, the area of inhibition were 
almost the same and exhibited very high activity in crude 
extract, while in fractions F1 to F3, it showed optimum 
activity. It was further observed that the crude extract and 
fraction F3 showed high activity and fractions F1 and F2 
revealed weak activity against M. canis. The crude 
extract and fractions F1 to F3 remained totally ineffective 
in killing C. albicans and C. glabrata.  
B. asiatica crude extract inhibited spontaneous contrac-
tions at concentrations of 0.03, 0.1, 0.3 and 1.0 mg/ml by 
5.7 ± 4.8, 11.7 ± 9.3, 38 ± 8.5 and 100% (mean ± SEM, n 
= 3), respectively (Table 3), showing an antispasmodic 
effect. The contraction of smooth muscle preparations 
including rabbit jejunum was dependent upon an increase 
in the cytoplasmic free Ca++, which activates the 
contractile elements (Karaki et al., 1997; Grasa et al., 
2004). The increase in intracellular Ca++ was due to either 
influx    via   voltage  dependant   L-type   Ca++   channels  
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Table 4. Concentration-dependent relaxant effect 
of the crude extract of B. asiatica on K+-induced 
contractions of isolated rabbit jejunum 
preparations.  
 
Concentration (mg/ml) Relaxation (%) 
0.1 6.7 ± 4.4 
0.3 32.7 ± 9.8 
1.0 100 
 
 Values shown are mean ± SEM, n = 3. 
 
 
 
Table 5. High effective fractions amongst F1, F2 and F3 against various pathogens. 
 
Pathogen Common disease Active fraction 
Bacteria 
E. coli (Gram-negative) Gastroenteritis , UTI, Meningitis in infants, septicaemia F2 
S. boydi (Gram-negative) Dysentery, Diarrhea F3 
S. flexneri (Gram-negative) Diarrhea F3 
    
Fungi 
F. solani Onychomycosis, nails infection, cornea, plant diseases F1 
A. flavus Cause allergy, liver carcinoma, brain infections, plant diseases F1 
T. longifusus UTI infections, skin diseases F1 
 
 
 
(VDCs) or release from intracellular stores in the 
sarcoplasmic reticulum. Periodic depolarization regulates 
the spontaneous movements of intestine and at the 
height of depolarization, the action potential appears as a 
rapid influx of Ca++ via VDCs (Brading, 1981). The 
inhibitory effect of the plant extract on spontaneous 
movements of jejunum may be due to interference either 
with the Ca++ release or with the Ca++ influx through 
VDCs. In our earlier studies, we observed that the spas-
molytic effect of the medicinal plants was usually 
mediated through Ca++ channel blockade (Gilani et al., 
2007).  
To see whether the spasmolytic effect of this plant is 
also mediated via the same mechanism, the B. asiatica 
was tested on high K+ (80 mM) induced contraction, 
which was relaxed by the plant extract at 0.1, 0.3 and 1.0 
mg/ml by 6.7 ± 4.4, 32.7 ± 9.8 and 100% (mean ± SEM, n 
= 3), respectively (Table 4). At high concentration (> 30 
mM), K+ is known to cause smooth muscle contractions 
through opening of VDCs, thus allowing the influx of extra 
cellular Ca++ and causes a contractile effect (Bolton, 
1979), and a substance which causes inhibition of high 
K+-induced contraction is considered as an inhibitor of 
Ca++ influx (Fleckenstein, 1977, Godfraind et al., 1986).  
 
 
Conclusions 
 
The results of this study indicate that ethyl acetate (F2) 
and n-butanol (F3) fractions of B. asiatica are strong 
inhibitor of Gram negative bacteria such as S. boydi, S. 
flexneri and E. coli. Amongst all, the chloroform (F1) 
fraction possessed outstanding antifungal activity against 
A. flavus, F. solani and T. longifusus (Table 5). The crude 
extracts also exhibited antispasmodic and Ca ++ 
antagonist effects. Thus, this study showed that the 
medicinal plant B. asiatica contains antibacterial, anti-
fungal, antispasmodic and Ca++ antagonist constituents. 
The active fractions will be further investigated through 
bioassay guided isolation to obtain the crude drugs and 
active compounds. 
 
 
ACKNOWLEDGEMENT 
 
Higher Education Commission, Pakistan (HEC, Pakistan) 
is greatly acknowledged for providing financial support.  
 
 
REFERENCES 
 
Abdullah P (1974). Flora of West Pakistan. University of Karachi, 
Karachi, pp. 1-4. 
Bolton TB (1979). Mechanism of action of transmitters and other 
substances on smooth muscles. Physiol. Rev. 59: 606-718. 
Brading A (1981). How do drugs initiate contraction in smooth muscles. 
Trends Pharmacol. Sci. 2: 261-265. 
Farre A, Colombo M, Fort M, Gutierrez B (1991). Differential effects of 
various Ca2+ antagonists. Gen. Pharmacol. 22: 177-181. 
Fleckenstein A (1977). Specific pharmacology of calcium in 
myocardium, cardiac pacemakers, and vascular smooth muscle. Ann. 
Rev. Pharmacol. Toxicol. 17: 149-166. 
  
 
 
 
Gage AT (1904). The vegetation of the district of Minbu in upper Burma. 
Records of the Botanical Survey of India 3: 141-143. 
Garg SC, Dengre SL (1992). Composition of the essential oil from the 
leaves of Buddleja asiatica Lour. Flavour Fragr. J. 7: 125-127. 
Gilani A, Shaheen F, Zaman M, Janbaz K, Shah B, Akhtar M (1999). 
Studies on antihypertensive and antispasmodic activities of methanol 
extract of Acacia nilotica Pods. Phytother Res. 13: 665-669. 
Gilani AH, Bashir S, Khan A (2007). Pharmacological basis for the use 
of Borago officinalis in gastrointestinal, respiratory and cardiovascular 
disorders. J. Ethnopharmacol. 114: 393-399. 
Godfraind T, Miller R, Wibo M (1986). Calcium antagonism and calcium 
entry blockade. Pharmacol. Rev. 38: 321-416. 
Grasa L, Rebollar E, Arruebo MP, Plaza MA, Murillo MD (2004). The 
role of Ca+2 in the contractility of rabbit small intestine in-vitro, J. 
Physiol. Pharmacol. 55: 639-650. 
Guerrero LA (1921). Medicinal uses of Philippine plants. Philippines 
Bureau Forest. Bull. 22: 149-246. 
Hartwell J (1970). Plants used against cancer. Lloydia, 33: 87-94. 
Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano KI, Harada KI, 
Miyamoto S, Nakazawa H, Won KJ, Sato K (1997). Calcium 
movements, distribution and functions in smooth muscle. Pharmacol. 
Rev. 49: 157-230. 
Kavanagh F (1963). Analytical Microbiology. Natl. Acad. Press, London, 
pp. 125-141. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ali et al.        7683 
 
 
 
Lee S, Xiao C, Pei S (2008). Ethnobotanical survey of medicinal plants 
at periodic markets of Honghe Prefecture in Yunnan Province, SW 
China. J. Ethnopharmacol. 117: 362-377. 
Liao Y, Houghton P, Hoults J (1999). Novel and known constituents 
from Buddleja species and their activity against leukocyte eicosanoid 
generation. J. Nat. Prod. 62: 1241-1245. 
National Research Council (1996). Guide for the Care and Use of 
Laboratory Animals. National Academy Press, Washington, pp. 12-
35. 
Nepal HM (1970). Medicinal Plants of Nepal. Ministry of Forests, Kath- 
Mandu, pp. 105-106. 
Pande P, Tiwari L, Pande H (2007). Ethnoveterinary plants of 
Uttaranchal-A review. Ind. J. Trad. Knowl. 6: 444-458. 
Reis AS, Von S (1973). Drugs and Foods from Little-known Plants. 
Harvard University Press, Cambridge, pp. 221-223. 
Singh S, Mathur A, Sinha J, Singh N, Kohli R (1980). A Study on the 
Mechanism of the Hypotensive Activity of Buddleja asiatica 
(Newarpati). Pharm. Biol. 18: 83-87. 
Zheng X, Xing F (2009). Ethnobotanical study on medicinal plants 
around Mt. Yinggeling, Hainan Island, China. J. Ethnopharmacol. 
124: 197-210. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
